Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 93.88M | 84.05M | 80.25M | 75.40M | 70.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.88M | 84.05M | 80.25M | 75.40M | 70.50M |
| Cost of Revenue | 831.00K | -147.23M | 51.40M | 52.78M | 246.00K |
| Gross Profit | 93.05M | 231.28M | 28.85M | 22.62M | 70.26M |
| SG&A Expenses | 40.20M | 42.32M | 35.53M | 38.64M | 39.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -18.05M | -- | -- | -- |
| Total Operating Expenses | 97.50M | 85.45M | 88.75M | 91.42M | 96.99M |
| Operating Income | -3.62M | -1.40M | -8.50M | -16.02M | -26.49M |
| Income Before Tax | 6.08M | -24.82M | 6.09M | -10.13M | -24.08M |
| Income Tax Expenses | 1.06M | -1.05M | -2.64M | 1.49M | 357.00K |
| Earnings from Continuing Operations | 5.02M | -23.77M | 8.74M | -11.62M | -24.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.02M | -23.77M | 8.74M | -11.62M | -24.44M |
| EBIT | -3.62M | -1.40M | -8.50M | -16.02M | -26.49M |
| EBITDA | -2.76M | -235.00K | -7.47M | -15.03M | -25.48M |
| EPS Basic | 0.10 | -0.48 | 0.17 | -0.23 | -0.49 |
| Normalized Basic EPS | 0.01 | -0.26 | 0.08 | -0.13 | -0.30 |
| EPS Diluted | 0.10 | -0.48 | 0.17 | -0.23 | -0.49 |
| Normalized Diluted EPS | 0.01 | -0.26 | 0.07 | -0.13 | -0.30 |
| Average Basic Shares Outstanding | 50.09M | 50.05M | 50.02M | 50.01M | 49.88M |
| Average Diluted Shares Outstanding | 51.95M | 50.05M | 52.81M | 50.01M | 49.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |